Modeling Cancer Cell Growth Dynamics In vitro in Response to Antimitotic Drug Treatment

por Lorz, Alexander, Botesteanu, Dana-Adriana, Levy, Doron
Publicado 2017

Universal response in the RKO colon cancer cell line to distinct antimitotic therapies

por Lorz, Alexander, Botesteanu, Dana-Adriana, Levy, Doron
Publicado 2018

Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early Detection

por Botesteanu, Dana-Adriana, Lee, Jung-Min, Levy, Doron
Publicado 2016

Untargeted Metabolomic Analysis Combined With Multivariate Statistics Reveal Distinct Metabolic Changes in GPR40 Agonist-Treated Animals Related to Bile Acid Metabolism

por Doerfler, Hannes, Botesteanu, Dana-Adriana, Blech, Stefan, Laux, Ralf
Publicado 2021

Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first in class, proof-of-concept, single arm phase 2...

por Lee, Jung-Min, Nair, Jayakumar, Zimmer, Alexandra, Lipkowitz, Stanley, Annunziata, Christina M., Merino, Maria J., Swisher, Elizabeth M., Harrell, Maria I., Trepel, Jane B., Lee, Min-Jung, Bagheri, Mohammad H., Botesteanu, Dana-Adriana, Steinberg, Seth M., Minasian, Lori, Ekwede, Irene, Kohn, Elise C.
Publicado 2018